None of that is the scary number
Despite promising preclinical data, clinical trials in humans are extremely limited, and the compound remains largely experimental, with ongoing research required to fully characterize pharmacokinetics, optimal dosing, long-term safety, and potential off-target effects.
Microdose tirzepatide, $269 / monthly supply
Novo Nordisk's oral format is a swallowed tablet, while some compounded options use sublingual administration formats that differ from FDA-approved oral tablets and have not undergone FDA review as finished products
some patients obtain GLP-1s through compounded pharmacy channels or importation, reflecting willingness to switch formulations
Toxicol Appl Pharmacol 1984;74:11624